| Literature DB >> 24131020 |
M Yang1, M Xu, X Pan, Z Hu, Q Li, Y Wei, Y Zhang, J Rong, J Zhai, P He, S Hu, H Song, H Wu, F Zhan, S Liu, G Gao, Z Liu, Y Li, L Shen, A Huang, Z Lin, Z Liao, S Cao, Q Wei, Q Li, Q Lv, J Qi, T Li, O Jin, Y Pan, J Gu.
Abstract
The aim of the study was to investigate and compare the clinical manifestations between HLA-B27(+) and HLA-B27(-) ankylosing spondylitis (AS) patients in order to obtain knowledge of the impact of HLA-B27 status on AS, and to inform clinical treatment. A nationwide epidemiological investigation was performed from November 2008 to October 2010. The demographic data and clinical characteristics, and the status of HLA-B27 were collected using questionnaires and laboratory assay, respectively. A total of 2144 patients (78.5% males and 78.4% HLA-B27(+) AS patients) participated in this study. The percentages of males, patients with family history, and involvement of lumbar spine, thoracic spine and hip joints, were observed to be significantly higher in the HLA-B27(+) AS patients than in their HLA-B27(-) AS peers.Entities:
Keywords: HLA-B27; ankylosing spondylitis; clinical manifestations
Mesh：
Substances：
Year: 2013 PMID： 24131020 DOI： 10.1111/tan.12186
Source DB: PubMed Journal: Tissue Antigens ISSN： 0001-2815